ClinicalTrials.govpublic full text
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
ras-mutated metastatic colorectal cancer, mcrc, mss metastatic colorectal cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 902661
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.